ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Study of GS-3242 in Participants With HIV-1; Substudy-05

ClinicalTrials.gov ID: NCT07001319

Public ClinicalTrials.gov record NCT07001319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 5:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1 Substudy-05: GS-3242

Study identification

NCT ID
NCT07001319
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Gilead Sciences
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

  • BVY Drug
  • GS-3242 Drug
  • Standard of Care Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 28, 2025
Primary completion
Mar 31, 2026
Completion
Jan 31, 2027
Last update posted
Mar 4, 2026

2025 – 2027

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Franco Felizarta, MD Bakersfield California 93301 Recruiting
Ruane Clinical Research Group, Inc Los Angeles California 90036 Recruiting
Mills Clinical Research Los Angeles California 90069 Recruiting
Quest Clinical Research San Francisco California 94115 Recruiting
Washington Health Institute Washington D.C. District of Columbia 20017 Recruiting
Midland Florida Clinical Research Center, LLC DeLand Florida 32720 Recruiting
AIDS Healthcare Foundation - Northpoint Fort Lauderdale Florida 33308 Recruiting
Midway Immunology & Research Center, LLC Ft. Pierce Florida 34982 Recruiting
BLISS Health Orlando Florida 32803 Recruiting
Orlando Immunology Center, PA Orlando Florida 32803 Recruiting
Triple O Research Institute, P.A. West Palm Beach Florida 33407 Recruiting
Chatham County Health Department Savannah Georgia 31401 Recruiting
Indiana University School of Medicine Indianapolis Indiana 46202 Recruiting
Be Well Medical Center Berkley Michigan 48072 Recruiting
KC CARE Health Center Kansas City Missouri 64111 Recruiting
University of Cincinnati College of Medicine Cincinnati Ohio 45267 Recruiting
Central Texas Clinical Research Austin Texas 78705 Recruiting
Prism Health North Texas Dallas Texas 75208 Recruiting
North Texas Infectious Diseases Consultant's, P.A. Dallas Texas 75246 Recruiting
AXCES Research Group, LLC El Paso Texas 79902 Recruiting
AXCES Research Group, LLC Salt Lake City Utah 84102 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07001319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07001319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →